ARTICLE | Clinical News
Immunomedics preclinical data
October 28, 2002 8:00 AM UTC
IMMU said an anti-CEA antibody inhibited the growth of human medullary thyroid cancer in mice by 43%-69% compared to controls. The company said 99% growth inhibition was seen in mice given the antibod...